CIK 0001159036 · Large accelerated filer
HALOZYME THERAPEUTICS, INC.
Sign in to watch- Ticker
- HALO
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 880488686
- Phone
- (858) 794-8889
- Business address
- 12390 EL CAMINO REAL, SAN DIEGO, CA, 92130
- Former names
- HALOZYME THERAPEUTICS INC, GLOBAL YACHT SERVICES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $19,884,955
- in 5 filings, $19.9M under 10b5-1 plans
Net −$19,884,955. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-08-12 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −13,042 | $63.24 | $825K | 740,677 |
| 2025-08-12 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −6,958 | $64.00 | $445K | 733,719 |
| 2025-08-12 | Torley Helen PRESIDENT AND CEO | Option exercise · Option to Purchase Common Stock 10b5-1 | −20,000 | $8.11 | $162K | 216,569 |
| 2025-08-11 | Torley Helen PRESIDENT AND CEO | Option exercise 10b5-1 | +20,000 | $8.11 | $162K | 753,719 |
| 2025-08-11 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −18,717 | $63.01 | $1.2M | 735,002 |
| 2025-08-11 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −1,283 | $63.60 | $82K | 733,719 |
| 2025-08-11 | Torley Helen PRESIDENT AND CEO | Option exercise · Option to Purchase Common Stock 10b5-1 | −20,000 | $8.11 | $162K | 236,569 |
| 2025-07-10 | Torley Helen PRESIDENT AND CEO | Option exercise 10b5-1 | +20,000 | $8.11 | $162K | 753,719 |
| 2025-07-10 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −4,254 | $56.74 | $241K | 749,465 |
| 2025-07-10 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −15,746 | $57.62 | $907K | 733,719 |
| 2025-07-10 | Torley Helen PRESIDENT AND CEO | Option exercise · Option to Purchase Common Stock 10b5-1 | −20,000 | $8.11 | $162K | 256,569 |
| 2025-07-09 | Torley Helen PRESIDENT AND CEO | Option exercise 10b5-1 | +20,000 | $8.11 | $162K | 753,719 |
| 2025-07-09 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −19,792 | $56.43 | $1.1M | 733,927 |
| 2025-07-09 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −208 | $57.08 | $12K | 733,719 |
| 2025-07-09 | Torley Helen PRESIDENT AND CEO | Option exercise · Option to Purchase Common Stock 10b5-1 | −20,000 | $8.11 | $162K | 276,569 |
| 2025-07-08 | Torley Helen PRESIDENT AND CEO | Option exercise 10b5-1 | +20,000 | $8.11 | $162K | 753,719 |
| 2025-07-08 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −3,598 | $54.48 | $196K | 750,121 |
| 2025-07-08 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −16,402 | $55.74 | $914K | 733,719 |
| 2025-07-08 | Torley Helen PRESIDENT AND CEO | Option exercise · Option to Purchase Common Stock 10b5-1 | −20,000 | $8.11 | $162K | 296,569 |
| 2025-06-24 | Torley Helen PRESIDENT AND CEO | Option exercise 10b5-1 | +20,000 | $8.11 | $162K | 753,719 |
Page 17 of 26 · 513 trades